Compare UK prices. 40+ products · 22 retailers scored
PeptideClear UK

Encyclopedia entry

Peptide therapy for skin

OM

Oliver Mackman · Editorial director · Best Business Loans Ltd (16833937)

Last updated 2026-06-04

"Peptide therapy for skin" usually means topical cosmetic peptides: ingredients such as copper peptides (GHK-Cu) and Matrixyl that appear in serums and creams. These are sold as general-sale skincare and are a different category from the injectable research peptides that some clinics also market as peptide therapy. The two share the word "peptide" and little else.

The cosmetic peptides people mean

How this differs from injectable peptide therapy

The injectable research peptides marketed as peptide therapy (for example GHK-Cu in injectable form, or recovery peptides) are sold research use only and hold no UK authorisation for human therapeutic use. Topical cosmetic peptides in regulated skincare products are a separate, general-sale category. If skin is the interest, the cosmetic-peptide route is the everyday one.

Related: What is peptide therapy · Cosmetic peptides · The Pickart hypothesis (GHK-Cu) · Copper peptides.

Reviewed by Oliver Mackman, editorial director · last reviewed 2026-06-11T12:00:00.000Z
Trust, Legal and Governance

PeptideClear is a trading name of Best Business Loans Ltd, registered in England and Wales (company number 16833937). All services, operations and publications under the PeptideClear brand are delivered by Best Business Loans Ltd.

Legal and Registration

Registered in England and Wales. Company number 16833937. D‑U‑N‑S 234324824. ICO registered, reference ZC151816 (certificate, verify). Registered supplier on the UK Government's Find a Tender Service (FTS). Details publicly available via Companies House and OpenCorporates.

Standards and Governance

Operates under UK data protection and consumer standards. Aligns with UK GDPR, ISO 27001 and ISO 9001 principles. Working towards Cyber Essentials certification.

Domain Continuity

Primary domain peptideclear.co.uk. Business ownership, entity and services remain unchanged. Reviewed quarterly.